论文部分内容阅读
目的 :探讨在治疗儿童难治性肺炎支原体肺炎中采用甲泼尼龙的效果。方法 :将我院2013年1月到2015年12月收治的儿童难治性支原体肺炎患者120例进行研究,将这120例患者随机的分成观察组和对照组,每组60例,观察组的患者采用红霉素联合三代头孢菌素治疗的基础上,还采用甲泼尼龙进行治疗,对照组的患者仅仅采用红霉素联合三代头孢菌素进行治疗,对两组患者的退热时间、咳嗽缓解的时间进行对比分析。结果 :观察组的患者的退烧时间和咳嗽缓解情况都比对照组好,组间差异有统计学意义(P<0.05)。结论 :在对儿童难治性支原体肺炎进行治疗中,甲泼尼龙可以起到良好的效果,可以加快患者退烧的时间,并且可以缓解患者的咳嗽,值得在临床上应用。
Objective: To investigate the effect of methylprednisolone in the treatment of children with refractory Mycoplasma pneumoniae mycoplasma pneumonia. Methods: A total of 120 children with refractory mycoplasma pneumonia were enrolled in our hospital from January 2013 to December 2015. The 120 patients were randomly divided into observation group and control group, 60 cases in each group. The patients in observation group Patients with erythromycin combined with third-generation cephalosporin treatment, based on the use of methylprednisolone treatment, the control group of patients with erythromycin alone and third-generation cephalosporins for treatment, the two groups of patients with fever, cough Ease the time for comparative analysis. Results: The patients in the observation group had better fever relief time and cough relief than those in the control group. The differences between the two groups were statistically significant (P <0.05). CONCLUSION: Methylprednisolone can play a good role in the treatment of refractory mycoplasma pneumonia in children. It can accelerate the time of patients’ fever and relieve cough in patients, which is worthy of clinical application.